Mohammad Shahangir Biswas | Cellular Toxicity | Best Researcher Award

Published on by Cell Biologist

Dr. Mohammad Shahangir Biswas | Cellular Toxicity | Best Researcher Award

Dr. Mohammad Shahangir Biswas | University of Science & Technology Chittagong | Bangladesh

Dr. Mohammad Shahangir Biswas is a distinguished academician and researcher in the fields of Biochemistry, Biotechnology, and Public Health, currently serving as an Assistant Professor at the University of Science and Technology Chittagong (USTC), Bangladesh. He worked as a Postdoctoral Research Associate at the University of Wisconsin-Madison, USA. His academic and research journey reflects a dedication to global health issues, molecular biology, and neurophysiology. Previously, he served as Assistant Professor at Khwaja Yunus Ali University. He has co-authored more than 48 scientific publications, including multiple first-author articles in The Lancet and other Q1 journals. With international exposure and extensive research collaborations, he brings a strong commitment to scientific excellence. Dr. Biswas is fluent in English, speaks Japanese (basic), and is a native speaker of Bangla. He is passionate about public health advancement, biomedical research, and mentoring the next generation of scientists.

Publication Profiles:

Scopus
Orcid

Education:

Dr. Biswas earned his Ph.D. in Biochemistry/Medical Science from Tokyo Medical and Dental University, supported by the prestigious MEXT Scholarship. He later completed a Postdoctoral Fellowship at the University of Wisconsin-Madison, USA, contributing to advanced research in public health and neurophysiology. Prior to his doctoral studies, he obtained his M.Sc. (Thesis) and B.Sc. (Hons.) degrees in Biochemistry and Molecular Biology from the University of Rajshahi, Bangladesh. His early academic excellence earned him multiple scholarships and positioned him for a strong career in scientific research. This strong educational foundation, combined with global exposure, has equipped him with expertise in molecular biology, public health research, and biotechnological innovation. Dr. Biswas continues to use his academic training to lead impactful research, particularly in disease burden analysis and biomedical therapeutics.

Experience:

Dr. Mohammad Shahangir Biswas brings a diverse academic and research background spanning over a decade. He served as Assistant Professor at Khwaja Yunus Ali University and later joined USTC as Assistant Professor, soon to be active as an Associate Professor. He conducted impactful postdoctoral research at the University of Wisconsin-Madison, contributing to global public health research initiatives. His teaching and research cover Biochemistry, Biotechnology, Neurophysiology, and Public Health. In addition to his teaching roles, Dr. Biswas is a Senior Collaborator in the Global Burden of Disease (GBD) Study, contributing to several high-impact international publications. His strong leadership, grant acquisition, and mentoring skills have made him an influential figure in Bangladesh’s biomedical research landscape. He remains dedicated to fostering collaborative research and academic excellence both locally and internationally.

Awards and Honors:

Dr. Biswas has received numerous awards and recognitions throughout his academic journey. Notably, he was awarded the Japanese MEXT Scholarship for his Ph.D. studies in Japan—a highly competitive and prestigious international award. His undergraduate and postgraduate achievements at the University of Rajshahi were recognized with merit-based scholarships. Additionally, he received an R&D Grant from the Ministry of Science and Technology, Bangladesh, for conducting impactful research. His research contributions to major international collaborations such as the Global Burden of Disease Study have further established his credibility and excellence in global health research. His work has been accepted in top-tier journals including The Lancet and JACC, cementing his role as a leading researcher from Bangladesh on the global stage. These honors reflect his dedication, academic brilliance, and contributions to advancing medical science, especially in the fields of public health, neurodegeneration, and biochemistry.

Research Focus:

Dr. Shahangir Biswas’s research focuses on the molecular basis of disease, global health burden, neurodegeneration, and biomedical intervention strategies. He has contributed significantly to the Global Burden of Disease (GBD) Study, publishing extensively on cancer, cardiovascular diseases, and immunization trends. His work integrates biochemistry, biotechnology, and public health, aiming to identify mechanistic pathways of diseases like Alzheimer’s and tuberculosis, and develop therapeutic interventions. Additionally, he explores snake venom biochemistry, vaccine development, and the impact of social factors such as social media on mental health. Dr. Biswas is passionate about interdisciplinary research combining molecular diagnostics, bioinformatics, and global epidemiological data. His current work includes identifying biomarkers, assessing toxicology impacts, and predicting future disease trends using large-scale datasets. With over 48 peer-reviewed publications, he maintains a strong collaboration network internationally and is a vocal advocate for translational research that informs policy and clinical practice.

Publications Top Notes: 

  1. The global, regional, and national burden of cancer, 1990–2023 – The Lancet

  2. The global burden of cancer: Forecasts to 2050 – The Lancet, Accepted

  3. Global trends in childhood vaccination coverage 1980–2023 – The Lancet, Accepted

  4. Burden of Cardiovascular Diseases in 204 countries (1990–2023) – JACC, Accepted

  5. Biochemical Profile of Bangladeshi Russell’s Viper Venom – Journal of Toxicology, Accepted

  6. Neurodegeneration in Alzheimer’s Disease: Mechanisms and Therapies – Advanced Neurology, Accepted

  7. Musculoskeletal Extrapulmonary TB in Lagos, Nigeria – Health Sci Rep, Accepted

  8. Cytokines and Vascular Inflammation in Viral Infections – Health Sci Rep, Accepted 2

  9. Social Media and Mental Health of Young Adults in Bangladesh – Health Sci Rep, Accepted

  10.  Emerging Evidence on HKU5-CoV-2 – Romanian Journal of Infectious Diseases

Conclusion:

In conclusion, Dr. Mohammad Shahangir Biswas is a highly suitable candidate for the Best Researcher Award, given his consistent and impactful contributions to biomedical and public health research, his impressive publication record in world-renowned journals, and his strong academic foundation. He has demonstrated a deep commitment to advancing scientific knowledge with global relevance and interdisciplinary reach. With continued strategic focus on leadership roles in research, mentorship, and innovation, Dr. Biswas is well-positioned not only to receive this award but also to make even greater contributions to science and society in the years ahead.

Jean-Marc LEMAITRE | Cellular Senescence Aging | Best Researcher Award

Published on by Cell Biologist

Dr. Jean-Marc LEMAITRE | Cellular Senescence Aging | Best Researcher Award

Dr. Jean-Marc LEMAITRE, INSERM UMR1183, France

Jean-Marc Lemaitre is a French biomedical researcher internationally renowned for his groundbreaking work on cellular reprogramming and aging reversal. Born on October 14, 1963, he is currently based at the Institute for Regenerative Medicine and Biotherapies (IRMB) in Montpellier, where he serves as co-director. His work has transformed the understanding of how aged cells can be rejuvenated, offering new hope for regenerative therapies. With a strong academic and clinical research background, Lemaitre has authored over 100 scientific articles and books on senescence, stem cells, and epigenetics. He is a board member of several scientific societies and journals, and continues to drive research at the frontier of aging science. Lemaitre is also a public science communicator and author, helping bridge cutting-edge biology with societal challenges related to aging. His passion for improving human health through innovative science places him at the forefront of biomedical research in France and globally.

Publication Profile:

Orcid

Google Scholar

Strengths for the Award:

  1. Pioneering Work in Aging Reversal
    Lemaitre was among the first scientists to show that senescent human cells can be rejuvenated, contributing significantly to cellular reprogramming and epigenetic longevity science.

  2. High-Impact Publications & Scientific Output
    Authored or co-authored over 100 scientific works, including in Nature Aging, Molecular Cell, Scientific Reports, and PNAS. His studies are cited globally in aging, regenerative medicine, and stem cell therapy.

  3. Institutional Leadership
    As Co-Director and Co-founder of IRMB, he manages a research institute with 180+ staff, positioning him as a key scientific leader in France.

  4. Scientific Recognition
    Member of scientific editorial boards and committees (e.g., Cells journal, Ligue Contre le Cancer), and board member of FSSCR, reflecting sustained leadership in the stem cell field.

  5. Translational & Interdisciplinary Impact
    His research has led to clinical insights in dermatology, osteoarthritis, and cardiology, demonstrating broad biomedical relevance beyond aging biology.

  6. Public Engagement and Science Communication
    Author of books like “Guérir la Vieillesse” and “Décider de son âge”, he bridges scientific knowledge with public interest in health and longevity.

Areas for Improvement:

  1. Expanded International Collaborations
    While Lemaitre collaborates across disciplines, further integration into global consortia or partnerships with biotech/pharma could amplify the translational value of his work.

  2. Visibility in Policy or Global Aging Initiatives
    Participation in policy advisory boards or international aging panels (e.g., WHO, UN Decade of Healthy Aging) would enhance his influence in shaping public health approaches to aging.

  3. Startups or Technology Transfer
    Commercialization of his discoveries (e.g., senescence therapies or reprogramming protocols) through startups or IP licensing would elevate his impact on innovation and real-world application.

Education:

Jean-Marc Lemaitre’s academic journey is rooted in molecular and developmental biology. He earned his DEA (Diplôme d’Études Approfondies) in Developmental Biology from Paris 6 University in 1991. His Doctorate (PhD) followed in 1995 from Paris 7 University, with research conducted at the esteemed Institut Jacques Monod in molecular and cellular biology. His early focus on the fundamental processes of cell development laid the groundwork for his future expertise in aging and regenerative medicine. In 2005, Lemaitre earned his Habilitation to Direct Research (HDR) from Montpellier University Medical School, a prestigious credential that allowed him to lead independent research projects. His educational path reflects a consistent and deep engagement with life sciences and a strong commitment to academic excellence. These milestones set the foundation for his leading role in cellular reprogramming and senescence-related research at both national and international levels.

Experience:

Jean-Marc Lemaitre has amassed over 30 years of professional experience in biomedical research, with a major focus on aging, senescence, and regenerative medicine. Since 2015, he has served as Co-Director and Cofounder of the IRMB (Institute for Regenerative Medicine and Biotherapies), which now houses over 180 researchers. His professional base is at the Saint Eloi Hospital in Montpellier, where he contributes both to translational research and clinical collaborations. Between 2014 and 2018, he held a Contrat d’Interface at CHU Montpellier, strengthening ties between research and healthcare. His pioneering work in cellular reprogramming earned international acclaim for demonstrating that senescent human cells could be rejuvenated using induced pluripotent stem cell (iPSC) technology. Lemaitre also plays leadership roles in research consortia such as the FHU REGENHAB and is an elected member of scientific committees, including the LIGUE Contre le Cancer du Septentrion. His experience is both deep and influential in shaping modern aging research.

Awards and Honors:

Jean-Marc Lemaitre has been recognized multiple times for his leadership and innovation in biomedical science. He was elected to the Scientific Committee of the LIGUE Contre le Cancer du Septentrion in 2019, reflecting his growing influence in translational medicine. In 2015, he co-founded and became Co-Director of IRMB, an institute now pivotal in stem cell and regenerative therapies. From 2014 to 2018, he was awarded a Contrat d’Interface at CHU Montpellier, enhancing integration between research and clinical practice. His work has also earned him positions on international editorial boards, including the “Cells” journal since 2020. In 2007, he co-founded and became a board member of the French Society for Stem Cell Research (FSSCR). These honors reflect not only the quality of his scientific contributions but also his dedication to mentorship, institution-building, and public engagement in science. He remains a key figure in aging and regenerative medicine globally.

Research Focus:

Jean-Marc Lemaitre’s research centers on cellular aging, senescence, and regenerative medicine. He is internationally renowned for demonstrating that aged or senescent human cells can be reprogrammed back to a pluripotent state—effectively reversing aging markers. His team has been at the forefront of identifying epigenetic mechanisms involved in aging and developing short reprogramming protocols to extend healthspan. He works extensively on senotherapeutics—interventions targeting the senescent cells that drive aging and disease—and has published seminal studies on skin aging, musculoskeletal regeneration, and systemic rejuvenation. Lemaitre is also a thought leader in developing blood-based epigenetic clocks to monitor aging and predict mortality. His integrative approach blends molecular biology, stem cell science, and translational medicine to uncover ways to slow or reverse aging processes. His work opens promising therapeutic avenues for treating age-related diseases, improving healthspan, and potentially redefining biological age through cellular reprogramming technologies.

Publications Top Notes:

  1. Disc-Derived iPSCs and Environmental Cues for Nucleus Pulposus Regeneration (Tissue Eng Part A, 2025)

  2. Blood-Based Epigenetic Clock for Intrinsic Capacity and Mortality (Nat Aging, 2025)

  3. Niacinamide and Hyaluronic Acid for Skin Aging: Clinical Correlation (Sci Rep, 2024)

  4. Décider de son âge (Book, 2024 – Allary Editions)

  5. Therapeutic Approaches Targeting Senescent Cells (Cells, 2023)

  6. Guérir la Vieillesse (Book, 2022 – Humensciences)

  7. Single Short Reprogramming Increases Healthspan (Aging, 2022)

  8. Epigenetic Mechanism Linking Early Reprogramming to Lifespan (Aging Cell, 2022)

  9. DNMT1-Driven 4D Genome Rewiring in Senescence (Molecular Cell, 2020)

  10. DNA Replication Timing as Marker in Progeroid Diseases (PNAS, 2017)

Conclusion:

Jean-Marc Lemaitre is a highly deserving candidate for the Best Researcher Award. He combines groundbreaking research in cellular aging and epigenetics with institutional leadership and public engagement. His work has transformed the understanding of biological aging, making him one of the most influential biomedical scientists in Europe in this domain. The award would not only recognize his scientific excellence but also highlight the increasing importance of healthy aging, regenerative medicine, and cellular rejuvenation in modern medicine.

Jiaqiang Huang | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Jiaqiang Huang | Molecular Mechanisms Signaling | Best Researcher Award

Assoc. Prof. Dr. Jiaqiang Huang , China Agricultural University , China

Dr. Huang JQ is an associated professor at China Agricultural University, specializing in animal nutrition, food science, and health. With a strong background in selenium and selenoproteins, Dr. Huang has made significant contributions to understanding their biological effects, particularly in livestock and poultry production. His work explores the prevention and regulation of oxidative stress, intestinal health, and the development of selenium-rich products. Dr. Huang is recognized for his expertise in molecular regulation mechanisms and has published extensively in top-tier journals. He also holds several leadership positions in academic research, contributing to global advances in animal nutrition and health.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Academic Background: Dr. Huang JQ has a comprehensive academic foundation, having completed a Bachelor’s, Master’s, and Doctoral degree in relevant fields, such as Animal Nutrition, Human Health, and Food Science, from prestigious institutions like Yangzhou University, Sichuan Agricultural University, and China Agricultural University. His consistent academic progress over the years reflects his deep commitment and passion for his field.
  2. Expertise in Selenium and Selenoproteins Research: Dr. Huang’s research is centered around the biological effects of selenium and selenoproteins, with a particular focus on their molecular regulation mechanisms and their role in preventing oxidative stress in livestock and poultry. This expertise is highly significant, given the potential of selenium to improve animal health and productivity, contributing to sustainable and efficient agricultural practices.
  3. Pioneering Work in Intestinal Health and Oxidative Stress: His research contributes significantly to understanding how oxidative stress impacts livestock and poultry health and how selenium can serve as a mitigating factor. This aligns with the current need to develop sustainable approaches for livestock health management, including reducing the reliance on antibiotics and improving gut health.
  4. Impressive Publication Record: Dr. Huang has published numerous high-impact papers in reputed journals such as Nutrients, Advanced Science, J Nutr, and Redox Biol, among others. His work has led to several innovative discoveries, particularly in areas like ferroptosis modulation, radiation resistance, and metabolic disorders, showing his versatility in addressing complex issues in animal nutrition and health.
  5. Collaborative Approach and Leadership: As an associate professor at China Agricultural University, Dr. Huang has not only contributed through his individual research but also led and collaborated on numerous interdisciplinary projects. His research is cited extensively, highlighting his leadership and influence within the scientific community.
  6. Global Impact and Relevance: Dr. Huang’s work on selenium-enriched probiotics, selenium-based nanocomposites, and oxidative stress management has the potential for global impact, addressing issues such as malnutrition, oxidative damage, and metabolic diseases. His research is timely and aligns with global health and agricultural goals, making him a highly relevant figure in the research community.

Areas for Improvement:

  1. Broader Outreach of Research Findings: While Dr. Huang’s publications are impressive, there may be a need for more active engagement with non-academic audiences, including policy-makers, industry stakeholders, and the public. Translating his research findings into practical applications in agricultural practices and public health could enhance the societal impact of his work.
  2. Expanding Interdisciplinary Collaborations: While Dr. Huang has a strong background in nutrition and health, future work could benefit from increased collaboration with researchers from other fields such as genetic engineering, microbiology, and environmental sciences. This could help broaden the scope of his research and address complex global issues such as climate change, sustainable agriculture, and bioengineering.
  3. Diversifying Research Focus: Although selenium research is central to Dr. Huang’s work, diversifying into related fields, such as personalized nutrition or the development of innovative biotechnological solutions for sustainable farming, could open up new avenues for his research and expand its applicability in diverse agricultural and medical contexts.

Education

Dr. Huang completed his Bachelor’s in Animal Nutrition from Yangzhou University in 2009. He earned a Master’s in Animal Nutrition and Human Health from Sichuan Agricultural University in 2012. He obtained a Doctorate in Food Science from China Agricultural University in 2015, followed by postdoctoral work at the same institution from 2016 to 2020. As an associated professor since 2020, Dr. Huang has further advanced his research into selenium’s role in livestock and human health.

Experience

Dr. Huang’s research journey began in 2015 with a doctoral focus on food science, followed by postdoctoral research at China Agricultural University. He became an associated professor in 2020, continuing his exploration of selenium’s effects on oxidative stress, intestinal health, and nutrition. His research has led to multiple groundbreaking publications in top journals. With a career dedicated to academic research, Dr. Huang collaborates with international experts, leads innovative projects, and educates future scholars in animal nutrition and food science.

Research Focus

Dr. Huang’s research is focused on the biological effects of selenium and selenoproteins in livestock and poultry, with a particular emphasis on oxidative stress regulation, intestinal health, and selenium-rich products. His work investigates molecular mechanisms behind selenium’s impact on animal health, exploring its potential to improve resistance to diseases and oxidative damage. By developing selenium-enriched products, Dr. Huang aims to enhance livestock and poultry production efficiency while promoting human health. His interdisciplinary approach combines nutrition, molecular biology, and food science to advance the field.

Publications Top Notes:

  1. Advances of Selenium in Poultry Nutrition and Health
  2. Amelioration of LPS-induced Jejunum Injury and Mucus Barrier Damage in Mice by IgY Embedded in W/O/W Emulsion
  3. Roles of Probiotics, Prebiotics, and Postbiotics in B-cell Mediated Immune Regulation
  4. Protective Effect of IgY Embedded in W/O/W Emulsion on LPS Enteritis-Induced Colonic Injury in Mice
  5. Effect of Selenium and Selenoproteins on Radiation Resistance
  6. SELENOI Functions as a Key Modulator of Ferroptosis Pathway in Colitis and Colorectal Cancer
  7. Hepatocyte-specific Selenoi Deficiency Predisposes Mice to Hepatic Steatosis and Obesity
  8. Stabilization by Chaperone GroEL in Biogenic Selenium Nanoparticles Produced from Bifidobacterium animalis H15 for the Treatment of DSS-Induced Colitis
  9. Biomimetic MicroRNAs-Selenium-Nanocomposites for Targeted and Combined Hyperlipidemia Therapy
  10. Protective Effects of Selenium Nanoparticles Against Bisphenol A-Induced Toxicity in Porcine Intestinal Epithelial Cells

Conclusion:

Dr. Huang JQ is a highly deserving candidate for the Best Researcher Award due to his expertise in the biological effects of selenium and selenoproteins, his innovative research in animal nutrition, and his leadership in advancing scientific knowledge in oxidative stress management and intestinal health. His extensive publication record, interdisciplinary collaborations, and potential to impact global agricultural and health practices further strengthen his candidacy. While there are areas for improvement in outreach and diversification, his work is impactful and has the potential for long-lasting contributions to both science and society.